World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
96
Citations
44487
World Ranking
842
National Ranking
473

Medicine

D-Index
96
Citations
44518
World Ranking
9521
National Ranking
4908

Charles R. Rinaldo publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Charles R. Rinaldo sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 459 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Charles R. Rinaldo D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Charles R. Rinaldo sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 96 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Charles R. Rinaldo is affiliated with the University of Pittsburgh in the United States and has conducted extensive research primarily in the fields of Medicine and Immunology and Microbiology. Their scholarly work integrates several subfields including Virology, Epidemiology, Infectious Diseases, Immunology, and Emergency Medicine.

The main topics in Charles R. Rinaldo's research focus on HIV and related health challenges. These encompass HIV Research and Treatment, HIV-related health complications and treatments, Immune Cell Function and Interaction, HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, Cytomegalovirus and herpesvirus research, as well as SARS-CoV-2 and COVID-19 research.

They have published a range of papers in reputable venues, including but not limited to bioRxiv (Cold Spring Harbor Laboratory), UNC Libraries, The Journal of Immunology, The Journal of Infectious Diseases, and Open Forum Infectious Diseases.

  • Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy, 2020, The Journal of Infectious Diseases
  • Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial, 2020, The Lancet
  • Signature changes in gut microbiome are associated with increased susceptibility to HIV-1 infection in MSM, 2021, Microbiome
  • COVID-19 symptoms and SARS-CoV-2 infection among people living with HIV in the US: the MACS/WIHS combined cohort study, 2020, HIV Research & Clinical Practice
  • Low Influenza Vaccine Effectiveness Against A(H3N2)-Associated Hospitalizations in 2016-2017 and 2017-2018 of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN), 2020, The Journal of Infectious Diseases

Charles R. Rinaldo frequently collaborates with other researchers, including Bernard Macatangay, Phyllis C. Tien, Robbie B. Mailliard, John W. Mellors, and Sharon A. Riddler, with the number of joint publications ranging from 7 to 16.

Best Publications

  • Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma

    John W. Mellors;Charles R. Rinaldo;Phalguni Gupta;Roseanne M. White

  • Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

    Michael Dean;Mary Carrington;Cheryl Winkler;Gavin A. Huttley

  • Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection

    John W. Mellors;Alvaro Muñoz;Janis V. Giorgi;Joseph B. Margolick

  • THE MULTICENTER AIDS COHORT STUDY: RATIONALE, ORGANIZATION, AND SELECTED CHARACTERISTICS OF THE PARTICIPANTS

    Kaslow Ra;Ostrow Dg;Detels R;Phair Jp

  • Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection

    Richard A. Kaslow;Mary Carrington;R. Apple;L. Park

  • Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion

    John W. Mellors;Lawrence A. Kingsley;Charles R. Rinaldo;John A. Todd

  • Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection

    Raj Shankarappa;Joseph B. Margolick;Stephen J. Gange;Allen G. Rodrigo

  • KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.

    Shou-Jiang Gao;Lawrence Kingsley;Ming Li;Wei Zheng

  • The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group.

    John Phair;Alvaro Muñoz;Roger Detels;Richard Kaslow

  • High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors.

    C Rinaldo;X L Huang;Z F Fan;M Ding

  • Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men.

    B. F. Polk;R. Fox;R. Brookmeyer;Sukon Kanchanaraksa

  • Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma

    Shou Jiang Gao;Lawrence Kingsley;Donald R. Hoover;Thomas J. Spira

  • HIV and aging: State of knowledge and areas of critical need for research. a report to the NIH office of AIDS research by the HIV and aging working group

    Kevin P. High;Mark Brennan-Ing;David B. Clifford;Mardge H. Cohen

  • Natural History of Human Immunodeficiency Virus Type 1 Viremia after Seroconversion and Proximal to AIDS in a Large Cohort of Homosexual Men

    Robert H. Lyles;Alvaro Muñoz;Traci E. Yamashita;Holly Bazmi

  • RISK FACTORS FOR SEROCONVERSION TO HUMAN IMMUNODEFICIENCY VIRUS AMONG MALE HOMOSEXUALS: Results from the Multicenter AIDS Cohort Study

    Lawrence A. Kingsley;Richard Kaslow;Charles R. Rinaldo;Katherine Detre

  • Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates

    Suzanne E. Ohmit;Mark G. Thompson;Joshua G. Petrie;Swathi N. Thaker

  • Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication.

    Arne Schneidewind;Mark A. Brockman;Mark A. Brockman;Ruifeng Yang;Rahma I. Adam

  • HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression.

    Linda L. Baum;Kelly J. Cassutt;Kevin Knigge;Roli Khattri

  • High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors.

    Phalguni Gupta;John Mellors;Lawrence Kingsley;Sharon Riddler

  • Persistent GB virus C infection and survival in HIV-infected men.

    Carolyn F. Williams;Donna Klinzman;Traci E. Yamashita;Jinhua Xiang

  • Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection.

    Janis V. Giorgi;Robert H. Lyles;Jose L. Matud;Traci E. Yamashita

  • HIV Status, Burden of Comorbid Disease, and Biomarkers of Inflammation, Altered Coagulation, and Monocyte Activation

    Kaku A. Armah;Kathleen McGinnis;Jason Baker;Cynthia Gibert

  • Mechanisms of immunosuppression in cytomegaloviral mononucleosis.

    Charles R. Rinaldo;Walter P. Carney;Bonnie S. Richter;Paul H. Black

  • The effects on survival of early treatment of human immunodeficiency virus infection.

    Neil M.h. Graham;Scott L. Zeger;Lawrence P. Park;Sten H. Vermund

  • Low Sensitivity of Rapid Diagnostic Test for Influenza

    Timothy M. Uyeki;Ramakrishna Prasad;Charles Vukotich;Samuel Stebbins

  • DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages.

    Giovanna Rappocciolo;Frank J. Jenkins;Heather R. Hensler;Paolo Piazza

Frequent Co-Authors

Roger Detels
Roger Detels University of California, Los Angeles
Joseph B. Margolick
Joseph B. Margolick Johns Hopkins University
Lawrence A. Kingsley
Lawrence A. Kingsley University of Pittsburgh
John P. Phair
John P. Phair Northwestern University
Lisa P. Jacobson
Lisa P. Jacobson Johns Hopkins University
Phalguni Gupta
Phalguni Gupta University of Pittsburgh
Richard A. Kaslow
Richard A. Kaslow Yale School of Medicine
Monto Ho
Monto Ho University of Pittsburgh
Alfred J. Saah
Alfred J. Saah MSD (United States)
John W. Mellors
John W. Mellors University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare fields such as nursing can broaden career opportunities. Many professionals consider advanced nursing degrees, including becoming a Nurse Practitioner, which offers a practical approach to patient care and research.

Those looking to balance education with other commitments may find the easiest online nurse practitioner programs particularly appealing. These programs provide flexible schedules without compromising quality learning.

Mental health is closely connected with immunological research, and specializing as a Psychiatric Mental Health Nurse Practitioner (PMHNP) is a growing field. Prospective students should consider the best pmhnp programs to gain access to strong clinical placements and hands-on experience.

Cost is a critical factor, and finding the cheapest psych np programs can ease financial burden while still offering comprehensive training. Such programs enable graduates to confidently enter the workforce.

After earning a Doctor of Nursing Practice, professionals can expect competitive compensation. Detailed information on the doctor of nursing practice salary by state helps graduates make informed decisions about where to practice.

Best Scientists Citing Charles R. Rinaldo

Trending Scientists

Recently Published Articles